Russell Saltzman

Abstract Peyronie’s Disease (PD) is characterized by fibrotic plaques in the penile tunica albuginea, causing curvature and painful erections. Current treatments have limited established efficacy. Platelet-Rich Plasma (PRP), known for modulating inflammation, offers a potential alternative. This randomized, placebo-controlled, crossover study at the University of Miami assesses PRP’s safety and efficacy for PD.

Abstract This retrospective descriptive analysis explores underrepresented minority men in our clinical trial for restorative therapy for erectile dysfunction and to identify strategies to promote diversity and inclusion in the study population. Demographic data were collected from all participants and the prevalence in our population was compared to the source population.

This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 8 print issues and online access 251,40 € per year only 31,43 € per issue Rent or buy this article Get just this article for as long as you need it $39.95 Prices may be subject to local taxes which are calculated during checkout Additional access options: Log in Learn about institutional subscriptions Read our FAQs Contact customer support References Masters WH, Johnson VE.